These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 29086461)

  • 1. T cell-mediated rejection is a major determinant of inflammation in scarred areas in kidney allografts.
    Lefaucheur C; Gosset C; Rabant M; Viglietti D; Verine J; Aubert O; Louis K; Glotz D; Legendre C; Duong Van Huyen JP; Loupy A
    Am J Transplant; 2018 Feb; 18(2):377-390. PubMed ID: 29086461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The causes, significance and consequences of inflammatory fibrosis in kidney transplantation: The Banff i-IFTA lesion.
    Nankivell BJ; Shingde M; Keung KL; Fung CL; Borrows RJ; O'Connell PJ; Chapman JR
    Am J Transplant; 2018 Feb; 18(2):364-376. PubMed ID: 29194971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to treatment and long-term outcomes in kidney transplant recipients with acute T cell-mediated rejection.
    Bouatou Y; Viglietti D; Pievani D; Louis K; Duong Van Huyen JP; Rabant M; Aubert O; Taupin JL; Glotz D; Legendre C; Loupy A; Lefaucheur C
    Am J Transplant; 2019 Jul; 19(7):1972-1988. PubMed ID: 30748089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does tubulitis without interstitial inflammation represent borderline acute T cell mediated rejection?
    Nankivell BJ; P'Ng CH; Chapman JR
    Am J Transplant; 2019 Jan; 19(1):132-144. PubMed ID: 29687946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.
    Gosset C; Viglietti D; Rabant M; Vérine J; Aubert O; Glotz D; Legendre C; Taupin JL; Duong Van-Huyen JP; Loupy A; Lefaucheur C
    Kidney Int; 2017 Sep; 92(3):729-742. PubMed ID: 28554738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical and pathological significance of borderline T cell-mediated rejection.
    Nankivell BJ; Agrawal N; Sharma A; Taverniti A; P'Ng CH; Shingde M; Wong G; Chapman JR
    Am J Transplant; 2019 May; 19(5):1452-1463. PubMed ID: 30501008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell mediated rejection revisited: Past, current, and future directions.
    Hara S
    Nephrology (Carlton); 2018 Jul; 23 Suppl 2():45-51. PubMed ID: 29968416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BK Virus Nephropathy: Histological Evolution by Sequential Pathology.
    Nankivell BJ; Renthawa J; Sharma RN; Kable K; O'Connell PJ; Chapman JR
    Am J Transplant; 2017 Aug; 17(8):2065-2077. PubMed ID: 28371308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell Mediated Rejection Associated Microvascular Inflammation in the Allograft Kidney: RNAseq Analysis Using the Banff Human Organ Transplant Gene Panel.
    Barwad A; Huang Y; Randhawa P
    Clin Transplant; 2024 Jul; 38(7):e15410. PubMed ID: 39033507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of Serial Protocol Biopsies Performed After 1 Year in Predicting Long-Term Kidney Allograft Function According to Histologic Phenotype.
    Zachariah MS; Dwivedi AK; Yip CS; Chang SS; Gundroo A; Venuto RC; Tomaszewski J; Patel SK; Sharma R
    Exp Clin Transplant; 2018 Aug; 16(4):391-400. PubMed ID: 29206090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of Perivascular Aggregates in Kidney Allografts: Evaluation of 1-Year Protocol Biopsies Using Recent Banff Classification.
    Masutani K; Nakagawa K; Matsukuma Y; Ueki K; Ataka E; Tsuchimoto A; Okabe Y; Nakamura M; Kitazono T; Nakano T
    Transplant Proc; 2024 Apr; 56(3):499-504. PubMed ID: 38320868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term adverse effects of early subclinical allograft inflammation in kidney transplant recipients with a rapid steroid withdrawal protocol.
    Mehta R; Bhusal S; Randhawa P; Sood P; Cherukuri A; Wu C; Puttarajappa C; Hoffman W; Shah N; Mangiola M; Zeevi A; Tevar AD; Hariharan S
    Am J Transplant; 2018 Jul; 18(7):1710-1717. PubMed ID: 29247472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Pathophysiology and Impact of Inflammation in Nonscarred Renal Interstitium: The Banff i Lesion.
    Nankivell BJ; P'Ng CH; Shingde M; Viswanathan S; Achan A; Renthawa J; Sharma RN; Chapman JR
    Transplantation; 2020 Apr; 104(4):835-846. PubMed ID: 31369519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney allograft failure in the steroid-free immunosuppression era: A matched case-control study.
    Alkadi MM; Kim J; Aull MJ; Schwartz JE; Lee JR; Watkins A; Lee JB; Dadhania DM; Seshan SV; Serur D; Kapur S; Suthanthiran M; Hartono C; Muthukumar T
    Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28921709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and pathological analyses of interstitial fibrosis and tubular atrophy cases after kidney transplantation.
    Shimizu T; Toma H; Hayakawa N; Shibahara R; Ishiyama R; Hayashida A; Fujimori D; Tsunoyama K; Ikezawa E; Kitajima S; Iida S; Ishida H; Tanabe K; Honda K; Koike J
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():26-30. PubMed ID: 26972969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular diagnosis of antibody-mediated rejection: Evaluating biopsy-based transcript diagnostics in the presence of donor-specific antibodies but without microvascular inflammation, a single-center descriptive analysis.
    Harmacek D; Weidmann L; Castrezana Lopez K; Schmid N; Korach R; Bortel N; von Moos S; Rho E; Helmchen B; Gaspert A; Schachtner T
    Am J Transplant; 2024 Sep; 24(9):1652-1663. PubMed ID: 38548057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed allograft inflammation following alemtuzumab induction for kidney transplantation.
    Heilman RL; Khamash HA; Smith ML; Chakkera HA; Moss AA; Reddy KS
    Clin Transplant; 2013; 27(5):772-80. PubMed ID: 23924146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation in areas of fibrosis: The DeKAF prospective cohort.
    Matas AJ; Helgeson ES; Gaston R; Cosio F; Mannon R; Kasiske BL; Hunsicker L; Gourishankar S; Rush D; Michael Cecka J; Connett J; Grande JP
    Am J Transplant; 2020 Sep; 20(9):2509-2521. PubMed ID: 32185865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of revised criteria for chronic active T cell-mediated rejection in the 2017 Banff classification: Surveillance by 1-year protocol biopsies for kidney transplantation.
    Nakagawa K; Tsuchimoto A; Ueki K; Matsukuma Y; Okabe Y; Masutani K; Unagami K; Kakuta Y; Okumi M; Nakamura M; Nakano T; Tanabe K; Kitazono T;
    Am J Transplant; 2021 Jan; 21(1):174-185. PubMed ID: 32484280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Histological Spectrum and Clinical Significance of T Cell-mediated Rejection of Kidney Allografts.
    Filippone EJ; Farber JL
    Transplantation; 2023 May; 107(5):1042-1055. PubMed ID: 36584369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.